baber/WOPTO huggingface dataset:
Patent CA-2634157-A1 (CA)
Inventor: BURANY STEPHEN JOSEPH
IPC: H01M8/04
Filed: 2007-02-08
Abstract: A number of factors cause undesirable reactions to occur that increases the rate of wear and degradation experienced by fuel cell components during shut down operations and restarting periods To mitigate concerns associated with the aforementioned, the present application is directed at an improved fuel cell module comprising i) a fuel cell stack including at least one fuel cell, each fuel cell including an anode electrode, a cathode electrode and an electrolyte medium arranged between the anode electrode and the cathode electrode, wherein during normal operation the anode electrode is provided with a first reactant and the cathode electrode is provided with a first mixture containing a second reactant and a non-reactive agent, 11) a parasitic load that connectable across the anode and the cathode electrodes, 111) a first reactant supply port, fluidly connectable to the anode electrode, for supplying the first reactant to the anode electrode, iv) a side stream fluidly connectable to the first reactant supply and the anode electrode, v) a reactant reservoir, fluidly connectable to the side stream, for storing an amount of the first reactant suitable for a shutdown process of the fuel cell module, whereby, in use when the fuel cell module is shutdown, the stored amount of the first reactant is drawn from the reactant reservoir and electrochemically reacts with the second reactant in the fuel cell module, to electrochemically consume the first and second reactants, thereby leaving a second mixture that substantially comprises the non-reactive agent, vi) and a pressure generating device, fluidly connectable to the side stream and positioned upstream of the reactant reservoir, for pressurizing and delivering the first reactant from the first reactant supply to the reactant reservoir.
Patent CA-2641993-A1 (CA)
Inventor: BOEHM ALEXANDER
IPC: F01N13/02
Filed: 2007-02-15
Abstract: Appareil de séparation des particules contenues dans les gaz d'échappement de moteurs à combustion interne, dans lequel l'écoulement des gaz d'échappement est guidé à travers un milieu filtrant dans lequel les particules peuvent être absorbées et retenues (4). L'invention devrait améliorer la séparation de manière économique par rapport aux filtres à particules conventionnels. En accord avec l'invention, le milieu filtrant (1) est constitué d'une mousse métallique à pores ouverts présentant au moins deux couches (11, 12, 13) qui diffèrent par l'épaisseur, la porosité et / ou la taille des pores dans la direction de passage de l'écoulement à travers le milieu filtrant.
Patent CA-2642815-A1 (CA)
Title: Selective culture medium
Inventor: FORD MICHAEL
IPC: C12Q1/04
Filed: 2007-02-23
Abstract: The present invention discloses a selective culture medium for detecting MRSA and selective drug or multidrug resistant microorganisms where the expression of said (multi)drug resistance is by virtue of the production by said microorganisms of .beta.-lactamase enzymes. The medium comprises : (i) a broad spectrum antibiotic capable of selectively inhibiting growth/replication of (a) organisms that do not produce .beta.-lactamase enzymes, (b) organisms that while producing .beta.-lactamase do not exhibit an ESBL or AmpC phenotype and (c) Methicillin-susceptible S. aureus, and (ii) a compound capable of inducing production of .beta.-lactamases in an organism, and which compound is included at a concentration that is subinhibitory for growth of said microorganism. Also provided are a method and kit for selectively isolating any MRSA and/or ESBL or AmpC .beta.-lactamase producing microorganisms present in a sample using the selective culture medium.
Patent CA-2643648-A1 (CA)
Title: Tissue and toilet seat-cover sanitary paper
Inventor: ISSACHAR DAVID
IPC: A47K13/16
Filed: 2007-02-26
Abstract: Disclosed are mode-A and mode-B folded sanitary paper devices in which each is appropriate for dual functions: (1) as a tissue paper for wiping and cleaning by a user, and (2) as a toilet seat-cover. Mode-A device is a folded continuous sanitary-paper strip comprising of plurality of detachable sections of tissue paper, where some of those sections are detachable toilet seat-covers in which each is defined by appropriate transverse toilet seat-cover perforation lines. Mode-B device is a folded sanitary-paper sheet that, in the preferred embodiment, contains only a single complete unit of a toilet seat-cover, and where mode-B sanitary-paper sheets are usually supplied to the consumer as individual units stack-folded in an appropriate dispenser. In preferred embodiments of both device modes, the sanitary papers, folded to produce at least three layers, are made of a duplex paper, where each surface best serves the intended function of that surface.
Patent CA-2644034-A1 (CA)
Inventor: ZHOU WEIPING
IPC: H05B44/00
Filed: 2006-12-28
Abstract: A seven colors light emitting module and a seven colors decorating lamp string including thereof. The seven colors light emitting module includes a lampshade made of a transparent plastic or synthetic resin, and a lamp socket on which three colors flashing light emitting diode, a zener diode, a current limiting resistance and a double-faced PCB are sealed. The three colors light emitting diodes connect with PCB and connect with the zener diode in parallel. One end of the zener diode or two ends of the zener diode connects with the current limiting resistance in series. A transparent epoxy resin or a silica gel is filled in the lampshade. The seven colors decorating lamp string include a power supply plugs, a power supply module which has a PCB and a commuting and filter circuit connected by a lead and a plurality of said seven colors light emitting modules.
Patent CA-2644445-A1 (CA)
Inventor: HOVENS CHRISTOPHER
IPC: A61K33/04
Filed: 2007-03-29
Abstract: The invention relates to the use of selenate or its pharmaceutically acceptable salts, in nutritional or supranutritional amounts, in methods and compositions for inhibiting the growth of benign tumor cells and treating or preventing benign tumors, particularly benign tumors in which the Akt signaling pathway is activated or in which Bcl 2 levels are elevated. Methods of preventing malignant conversion of benign tumors and benign tumor cells to malignant tumors or malignant tumor cells is also described.
Patent CA-2644811-A1 (CA)
Inventor: GAMLEN CAROL ANN
IPC: H05G1/02
Filed: 2008-11-25
Abstract: A pixel array arrangement is provided for a soft x-ray source. The arrangement includes: a window-frame structure having a plurality of channels passing therethrough, where each channel forms a pixel for the x-ray source; a cathode disposed on one side of each channel in the window-frame structure and operable to emit electrons into the channel; and an anode disposed in each cavity on an opposing side of the channel from the cathode and operable to emit x-ray radiation when electrons from the cathode impinge thereon, where the anode is configured to emit x-ray radiation at a diffused angle such that the x-ray radiation from a given pixel overlaps with x-ray radiation from adjacent pixels.
Patent CA-2645288-A1 (CA)
Title: Decontamination formulations
Inventor: PROUDLOCK KEVIN
IPC: C09K23/42
Filed: 2007-03-15
Abstract: The present application is concerned with compositions for providing phase-stable microemulsion decontamination formulations for treating surfaces, and in particular for treating surfaces contaminated with chemical and/or biological warfare agents.
Patent CA-2645996-A1 (CA)
Inventor: BRADLEY KERRY
IPC: A61N1/34
Filed: 2006-04-07
Abstract: Methods using multiple timing channels for electrode adjustment during set up of an implanted stimulator device are disclosed. In one embodiment, at least two conditions of electrodes (i.e., electrode combinations, pulse widths, pulse frequencies, pulse amplitudes) can be "simultaneously" tested by providing each condition in its own timing channel. In a preferred embodiment, the pulses in each of the timing channels are interleaved and non-overlapping to preserve the ability of the patient to assess the therapeutic feel of both and to allow some time between pulses for recovery. As well as allowing two sets of electrode conditions to be gauged at the same time, the technique allows the electrode to be manipulated during set up with ease and with a reduced possibility of providing the patient with erroneous results. For example, the two conditions in the two timing channels can comprise initial and target final conditions, and transitioning between from one to the other during device set up is facilitated as compared to the prior art because concerns with electrodes having inconsistent properties in both conditions are alleviated.
Patent CA-2646406-A1 (CA)
Inventor: REYES CHRISTOPHER L
IPC: C07K16/00
Filed: 2007-03-28
Abstract: The invention relates to antibodies which bind to insulin like growth factor receptor -1 (IGF-IR) and uses thereof, in particular in the diagnosis and treatment of cancer. Specific human and murine monoclonal antibodies which inhibit IGF-lR-mediated pro-survival and tumor proliferation pathways, and variants, fragments, and derivatives thereof are provided. Also provided are specific human and murine monoclonal antibodies which block the ability of the ligands, insulin like growth factor 1 (IGF-I) and insulin like growth factor 2 (IGF-2) to bind to IGF-IR, as well as fragments, variants and derivatives of such antibodies. The invention also includes polynucleotides encoding the above antibodies or fragments, variants or derivatives thereof, as well as vectors and host cells comprising such polynucleotides. The invention further includes methods of diagnosing and treating cancer using antibodies of the invention.
Patent CA-2648619-A1 (CA)
Title: Apparatus for providing multiple screens and method for dynamic configuration of the same
Inventor: LEE JONG-HO
IPC: H04N5/44
Filed: 2007-04-05
Abstract: The present invention relates to an apparatus for providing multiple screens and a method of dynamically configuring the multiple screens, and more particularly, to an apparatus for providing multiple screens and a method of dynamically configuring the multiple screens in which the focus of a certain region on a screen is controlled upon receiving a focus request command regarding a screen region that provides an application. The apparatus includes a digital signal processing module confirming whether a focus request regarding a first region on a screen has been issued, and an operational module operating the application on the screen on the basis of the confirmed result, where the first region displays an application included in received data information.
Patent CA-2650423-A1 (CA)
Inventor: BLOMS-FUNKE PETRA
IPC: A61K31/137
Filed: 2007-04-25
Abstract: The present invention relates to a combination comprising as components (a) the compound 3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol, and (b) Paracetamol or a derivative thereof, a pharmaceutical formulation and a dosage form comprising said combination as well as a method of treating pain, e.g. chronic or acute pain, characterized in that components (a) and (b) are administered simultaneously or sequentially to a mammal, wherein component (a) may be administered before or after component (b) and wherein components (a) or (b) are administered to the mammal either via the same or a different pathway of administration.
Patent CA-2651049-A1 (CA)
Inventor: LO YUK MING DENNIS
IPC: C12Q1/68
Filed: 2007-05-03
Abstract: This application describes the discovery that, in a pregnant woman, certa in genes (such as RASSF1A, APC, CASP8, RARB, SCGB3A1, DAB21P, PTPN6, THY1, T MEFF2, and PYCARD) originated from a fetus are highly methylated, whereas th e same genes of maternal origin are unmethylated. This discovery allows the easy detection of one or more of these methylated fetal genes in a biologica l sample from a pregnant woman, serving as a universal indicator of the pres ence of fetal DNA in the sample. These fetal methylation markers are particu larly useful as positive controls for a non-invasive analytical process duri ng which the quality and quantity of fetal DNA are monitored. These newly id entified fetal markers can also be measured directly for diagnosis of certai n pregnancy-related conditions.
Patent CA-2652467-A1 (CA)
Inventor: PRICE KENNETH NATHAN
IPC: C11D3/37
Filed: 2007-06-18
Abstract: Liquid detergent compositions comprising a polymer comprising polyacrylic acid monomers having a low number average molecular weight, ranging from about 1000 to about 10,000 amu, and a very low polydispersity, less than about 5, wherein the liquid detergent comprises less than about 50% of any non-aminofunctional solvent. The invention is also directed to liquid detergents compositions comprising beneficial mixtures of the low molecular weight, very low polydispersity polyacrylic acid based polymers with specific polymers.
Patent CA-2654366-A1 (CA)
Inventor: AGGAR SMAIL
IPC: A63H33/08
Filed: 2007-05-23
Abstract: Toy brick or block elements in particular of artistic and educational type, in which a plurality of brick elements made of a variety of different colors and a variety of different shapes are interlocked between each other by means of tongues and corresponding grooves to build a great variety of precise and coherent patterns or designs.
Patent CA-2655570-A1 (CA)
Title: Dha esters and use thereof in treatment and prevention of cardiovascular disease
Inventor: GARDETTE JEAN
IPC: A61K31/232
Filed: 2007-06-22
Abstract: The present invention relates to a docosahexaenoic acid ester with an alcohol chosen among the group-B vitamins or provitamins, advantageously comprised by: nicotinyl alcohol of the following formula (I), panthenol of the following formula (II), and inositol of the following formula (III) or with isosorbide of the following formula (IV) or isosorbide mononitrate of the following formula (V). It also relates to a method of preparation of same, a pharmaceutical composition comprising same and the use of same in the treatment or prevention of cardiovascular disease, in particular auricular fibrillation.
Patent CA-2658209-A1 (CA)
Title: Drinking vessel with receptacle for drippings
Inventor: SARAUER JAEGAR
IPC: A47G19/22
Filed: 2009-03-12
Abstract: The present invention relates to a drinking vessel having a top end, a bottom end, a drinking compartment and a base integrally connected to the drinking compartment. The base has an exterior surface facing outwards from the vessel that is imperforate to inhibit drippings from entering within the base. A receptacle is integral with and sealably connected to the base of the vessel to inhibit drippings from entering within the base under the drinking compartment. The receptacle extends radially outwardly from the base, around the base and at least partially towards the top end. It has an opening facing the top end of the vessel, whereby the receptacle is capable of receiving drippings from the top end of the vessel when the vessel is upright, inhibiting the drippings from escaping therefrom when drinking out of the vessel, and allowing drippings to freely exit therefrom when the vessel is upside down.
Patent CA-2658397-A1 (CA)
Title: Reconfigurable surface cleaning apparatus
Inventor: CONRAD WAYNE ERNEST
IPC: A47L5/24
Filed: 2009-03-13
Abstract: A surface cleaning apparatus includes a removably mounted portable surface cleaning apparatus, such as a hand vacuum cleaner, and is reconfigurable to two or more different cleaning configurations.
Patent CA-2660442-A1 (CA)
Title: New ketolases for the production of ketocarotenoids in tagetes
Inventor: SAUER GEORGE MATHER
IPC: A23K1/18
Filed: 2007-11-13
Abstract: New ketolases for the production of ketocarotenoids in Tagetes Abstract A ketolase having a polypeptide sequence SEQ ID NO:6, a sequence derived from SEQ ID NO:6 by substitution, insertion or deletion of aminoacids, which has an identity of at least 60% with the respective sequence SEQ. ID. NO: 6 or a functionally equivalent fragment of the sequences mentioned above and processes for production of ketocarotenoids in Tagetes.
Patent CA-2661014-A1 (CA)
Inventor: BOBROVA IRINA
IPC: A61P9/10
Filed: 2007-08-17
Abstract: Tissue protective compounds comprise the tetrapeptide structure A - B- C- D wherein each hydrogen of the N-terminus NH2 of amino acid residue A may independently optionally be replaced by C1-S alkyl or C1-S acyl, A - is an aromatic amino acid residue wherein the aromatic ring may optionally be substituted with one or more nitro group, B - is a diamino acid residue wherein the side chain amino group is substituted with C1-S acyl, C1-S alkyl, -B'-Ci-s acyl or -B'-Ci-s alkyl, wherein B' is an amino acid residue which may optionally be substituted with one or more nitro group, C - is GIy wherein the peptide N-H may optionally be changed to N-methyl, D - is Phe which is substituted on the aromatic ring with at least one nitro group and optionally further substituted on the aromatic ring with one or more group independently selected from nitro, fluoro, chloro, bromo, iodo, CF3 or CN, wherein the peptide N-H may optionally be changed to N-methyl, and the C-terminus C=O of amino acid residue D is substituted with NH2, NHC1-5 alkyl, NH-NH2, NH-NHC1-5 alkyl, or 0-C1-S alkyl, or the C-terminus is COOH or CH2OH, or a pharmaceutically acceptable salt thereof.
Patent CA-2661069-A1 (CA)
Inventor: PANKIW TANYA
IPC: A01K51/00
Filed: 2006-12-15
Abstract: The invention relates to a stabilized synthetic honey bee brood pheromone and methods of stabilizing the synthetic honey bee brood pheromone, thereby enabling the production and sustained use of commercial products based on that pheromone. The stabilized synthetic pheromone can be used to manipulate the behaviour and improve the performance of worker honey bees, resulting in an overall increased vigour of the hive. The stabilized synthetic honey bee pheromone composition comprises two or more of ethyl linoleate, ethyl linolenate, ethyl oleate, ethyl palmitate, ethyl stearate, methyl linoleate, methyl lmolenate, methyl oleate, methyl palmitate and methyl stearate and an antioxidant.
Patent CA-2665893-A1 (CA)
Inventor: VAN DER GOOT ATZE JAN
IPC: A23L13/60
Filed: 2007-10-03
Abstract: The present invention relates to a process for preparing fibrous edible structures. Particularly, this process uses an alignment technique together with cross-linking. Further, loose and structured fiber structures are described which can be used in or as a food composition.
Patent CA-2666134-A1 (CA)
Inventor: LAXAGUE MICHEL
IPC: C04B35/83
Filed: 2007-10-25
Abstract: The invention relates to a process for manufacturing a part made of a composite comprising a fibrous reinforcement densified by a matrix, which process comprises the steps of: production of a fibrous preform consolidated by impregnation (S4) of a fibrous texture comprising yarns by means of a liquid consolidation composition containing a precursor of a consolidating material and transformation (S7) by pyrolysis of the precursor made of consolidating material so as to obtain a consolidated preform of maintained shape; and densification (S8) of the consolidated fibrous preform by chemical vapour infiltration, characterized in that it includes, before the impregnation (S4) of the fibrous texture with the liquid consolidation composition, a step (S2) of filling the porosity of the yarns of said texture by means of a filling composition.
Patent CA-2671074-A1 (CA)
Title: Method and device for producing pig-iron based stainless steel without using a supply of electrical energy
Inventor: REICHEL JOHANN
IPC: C12C5/00
Filed: 2007-11-20
Abstract: The aim of the invention is to produce stainless steel for all stainless steel products both in the austenitic and the ferritic range, based on liquid pig-iron and FeCr solids, without using a supply of electrical energy. According to the invention, the liquid pig-iron, after being pre-treated in a blast furnace (1), is subjected to a DDD treatment (dephosphorisation, desiliconisation and desulphuration), is heated, finished or alloyed and deoxidated. The quantity of slag-free liquid pig-iron that has been pre-treated in the blast furnace (1) is separated and introduced into two classic "twin" AOD-L converters (2, 3), where the required chemical process steps (of the DDD treatment and of the heating, decarburisation and alloying stages) take place in parallel contrary processes using autogenous chemical energy, the DDD treatment being carried out first in the first twin AOD-L converter (2) and the decarburisation being carried out first in the second twin AOD-L converter (3).
Patent CA-2673268-A1 (CA)
Title: Method, system and apparatus for causing a communication device to join a communication session
Inventor: CLARK DAVID WILLIAM
IPC: H04M3/54
Filed: 2006-12-19
Abstract: According to embodiments of the present invention, there are provided a method, system and apparatus for joining a communication session. A method comprises receiving from a first communication device an indication of a desire of the first communication device to establish a communication session; the first communication device having been associated with a device group comprising the first communication device and at least one second communication device. The method further comprises determining if there exists an active communication session with the at least one second communication device. The method further comprises, responsive to existence of the active communication session, causing the first communication device to join the active communication session.
Patent CA-2674282-A1 (CA)
Inventor: VIKBERG JARI TAPIO
IPC: H04W68/00
Filed: 2008-01-14
Abstract: A method and apparatus for providing mobile switching center based services over a packet switched network is described. An interface between a mobile station and a packet mobile switching center is provided. The interface is used to transfer control plane information and user plane information between the mobile station and the packet mobile switching center over the packet switched network. A packet mobile switching center for a circuit switched network is also described. In one embodiment, a network controller handles control plane information from a packet switched core network and an interworking unit handles user plane information from the packet switched core network.
Patent CA-2674719-A1 (CA)
Inventor: KHANDEKAR AAMOD
IPC: H03M13/11
Filed: 2008-01-24
Abstract: Techniques to support low density parity check (LDPC) encoding and decoding are described. In an aspect, LDPC encoding and decoding of packets of varying sizes may be supported with a set of base parity check matrices of different dimensions and a set of lifting values of different powers of two. A base parity check matrix G of dimension mB~nB may be used to encode a packet of kB=nB-mB information bits to obtain a codeword of nB code bits. This base parity check matrix may be "lifted" by a lifting value of L to obtain a lifted parity check matrix H of dimension L~mB~L~nB. The lifted parity check matrix may be used to encode a packet of up to L~kB information bits to obtain a codeword of L~nB code bits. A wide range of packet sizes may be supported with the set of base parity check matrices and the set of lifting values.
Patent CA-2676626-A1 (CA)
Title: Composition adhesive pour etiquette auto-adhesive decollable
Inventor: FOUQUAY STEPHANE ANDRE
IPC: C09J153/02
Filed: 2008-01-31
Abstract: Composition adhésive thermofusible sensible à la pression (HMPSA) compren ant : a) de 25 à 50 % d'un mélange de copolymères blocs styréniques de type SBS et SB; b) de 45 à 75 % de résines tackifiantes compatibles ayant une tem pérature de ramollissement comprise entre 80 et 150 °C; c) de 0,5 à 5,5 % d 'acides gras dont la chaîne hydrocarbonée comprend de 10 à 22 atomes de carb one. Système multicouche comprenant une couche d'HMPSA, une couche support i mprimable et une couche protectrice adjacente. Etiquette auto-adhésive corre spondante et procédé de recyclage d'un article étiqueté avec décollement de ladite étiquette par immersion de l'article dans une solution aqueuse basiqu e à chaud.